MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1080/16078454.2025.2566570

Медицинская библиотека · Hematology (Amsterdam, Netherlands) · 2025

Pretreatment hemoglobin, myeloma subtype, and induction regimens as independent prognostic factors for survival after autologous stem cell transplantation in multiple myeloma: a retrospective cohort study.

Zhang Yong, Yang Guangzhong, Gao Wen, Chen Wenming

СтатьяПеревод пока не подготовлен

Аннотация

BACKGROUND

Autologous hematopoietic stem cell transplantation (auto-HSCT) is standard for eligible multiple myeloma (MM) patients, yet outcomes are heterogeneous. Besides established markers like cytogenetics and ISS, the independent prognostic value of pretreatment hemoglobin (Hb), myeloma subtype, and induction regimen requires clarification. This study aimed to assess these factors to improve risk stratification.

METHODS

We retrospectively analyzed 350 MM patients undergoing first auto-HSCT at Beijing Chao-Yang Hospital (2001-2019). The impact of baseline Hb (<10 vs. ≥10 g/dL), subtype (IgG vs. non-IgG), and induction regimen (bortezomib-based vs. others) on progression-free survival (PFS) and overall survival (OS) was evaluated using Kaplan-Meier and Cox regression.

RESULTS

With a median follow-up of 58 months, median PFS and OS were 42 months (95% CI 36-48) and 98 months (95% CI 83-113), respectively. Multivariate analysis identified three independent predictors of superior PFS: Hb ≥10 g/dL (HR = 0.65, P = 0.012), IgG subtype (HR = 0.72, P = 0.018), and bortezomib-based induction (HR = 0.58, P = 0.004). Attaining CR/VGPR post-transplant also significantly prolonged PFS versus PR or less (median 55 vs. 37 months, P = 0.044).

CONCLUSION

Pretreatment hemoglobin, IgG subtype, and bortezomib-based induction are independent predictors of survival after auto-HSCT. Hb, a simple and widely available marker, adds prognostic value beyond ISS and cytogenetics. Integrating these factors into prognostic models can help tailor therapy and improve patient management.

Для цитирования: Zhang Yong, Yang Guangzhong, Gao Wen, Chen Wenming. Pretreatment hemoglobin, myeloma subtype, and induction regimens as independent prognostic factors for survival after autologous stem cell transplantation in multiple myeloma: a retrospective cohort study.. Hematology (Amsterdam, Netherlands). 2025. DOI: 10.1080/16078454.2025.2566570.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.